Smith Jodi M, McDonald Ruth A
Department of Pediatrics, University of Washington, Seattle, WA, USA.
Pediatr Transplant. 2006 Nov;10(7):838-43. doi: 10.1111/j.1399-3046.2005.00481.x.
Viral infections are an important complication of transplantation. The introduction of more potent immunosuppressive agents over the past decade correlates with an increase in the rate of hospitalizations of transplant patients with infections. Specifically, viral infections have emerged as a major source of morbidity and mortality in transplantation. There are several potential intervention strategies in the face of emerging infections and it is likely that the approach will differ depending on the virus in question. These include viral surveillance and pre-emptive therapy, intervention of the transplant community, and policy change at the level of government, blood bank and organ procurement organizations. This review focuses on the emergence of the herpesviruses; HHV-6 and HHV-7. In addition, the issue of virus transmission through organ transplant is addressed with a discussion of West Nile virus and the rabies virus.
病毒感染是移植的一种重要并发症。在过去十年中,更有效的免疫抑制剂的引入与移植患者因感染而住院率的增加相关。具体而言,病毒感染已成为移植中发病和死亡的主要来源。面对新出现的感染,有几种潜在的干预策略,而且根据所涉及的病毒不同,方法可能会有所不同。这些策略包括病毒监测和抢先治疗、移植界的干预以及政府、血库和器官采购组织层面的政策改变。本综述重点关注疱疹病毒;人疱疹病毒6型和人疱疹病毒7型的出现。此外,还通过讨论西尼罗河病毒和狂犬病病毒来探讨通过器官移植传播病毒的问题。